According to Zomedica Pharmaceuticals's latest financial reports the company has $90.49 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.11 B | -40.96% |
2021-12-31 | $0.19 B | 214.48% |
2020-12-31 | $61.99 M | 12041.29% |
2019-12-31 | $0.51 M | -73.68% |
2018-12-31 | $1.94 M | -43.73% |
2017-12-31 | $3.44 M | 6.86% |
2016-12-31 | $3.22 M | -0.53% |
2016-02-29 | $0.08 M | |
2015-12-31 | $3.24 M | |
2015-02-28 | $0.14 M | -31.05% |
2014-02-28 | $0.2 M | 160.13% |
2013-02-28 | $0.07 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 130.05% | ๐บ๐ธ USA |